EMAIL THIS PAGE TO A FRIEND

Biomedical chromatography : BMC

Metabolism of methylstenbolone studied with human liver microsomes and the uPA⁺/⁺-SCID chimeric mouse model.


PMID 24496964

Abstract

Anti-doping laboratories need to be aware of evolutions on the steroid market and elucidate steroid metabolism to identify markers of misuse. Owing to ethical considerations, in vivo and in vitro models are preferred to human excretion for nonpharmaceutical grade substances. In this study the chimeric mouse model and human liver microsomes (HLM) were used to elucidate the phase I metabolism of a new steroid product containing, according to the label, methylstenbolone. Analysis revealed the presence of both methylstenbolone and methasterone, a structurally closely related steroid. Via HPLC fraction collection, methylstenbolone was isolated and studied with both models. Using HLM, 10 mono-hydroxylated derivatives (U1-U10) and a still unidentified derivative of methylstenbolone (U13) were detected. In chimeric mouse urine only di-hydroxylated metabolites (U11-U12) were identified. Although closely related, neither methasterone nor its metabolites were detected after administration of isolated methylstenbolone. Administration of the steroid product resulted mainly in the detection of methasterone metabolites, which were similar to those already described in the literature. Methylstenbolone metabolites previously described were not detected. A GC-MS/MS multiple reaction monitoring method was developed to detect methylstenbolone misuse. In one out of three samples, previously tested positive for methasterone, methylstenbolone and U13 were additionally detected, indicating the applicability of the method.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

03101
Ammonium iodide, puriss., ≥99%
H4IN
203467
Ammonium iodide, 99.999% trace metals basis
H4IN
221937
Ammonium iodide, ACS reagent, ≥99%
H4IN
296082
Diethyl ether, contains 1 ppm BHT as inhibitor, anhydrous, ≥99.7%
C4H10O
91238
Diethyl ether, analytical standard
C4H10O
09-1833
Diethyl ether, for residue analysis, suitable for 5000 per JIS
C4H10O
09-1855
Diethyl ether
C4H10O
E3708
Ethanethiol, 97%
C2H6S
W425800
Ethanethiol, ≥97%
C2H6S
80534
Ethanethiol, analytical standard
C2H6S
506818
Ethanethiol (ethyl mercaptan), analytical standard
C2H6S
791776
Potassium carbonate, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
CK2O3
P5833
Potassium carbonate, BioXtra, ≥99.0%
CK2O3
P1472
Potassium carbonate, meets USP testing specifications
CK2O3
367877
Potassium carbonate, 99.995% trace metals basis
CK2O3
590681
Potassium carbonate, anhydrous, powder, 99.99% trace metals basis
CK2O3
209619
Potassium carbonate, ACS reagent, ≥99.0%
CK2O3
310263
Potassium carbonate, ReagentPlus®, 99%
CK2O3
347825
Potassium carbonate, reagent grade, ≥98%, powder, −325 mesh
CK2O3
60108
Potassium carbonate, BioUltra, anhydrous, ≥99.0% (T)
CK2O3
60109
Potassium carbonate, puriss. p.a., ACS reagent, anhydrous, ≥99.0% (T)
CK2O3
12611
Potassium carbonate, meets analytical specification of Ph. Helv., puriss., anhydrous, granulated, 99-101% (calc. to the dried substance)
CK2O3
900501
Potassium carbonate, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, 99%
CK2O3
900502
Potassium carbonate, anhydrous, free-flowing, −325 mesh, Redi-Dri, reagent grade, ≥98%
CK2O3
71643
Sodium phosphate dibasic dihydrate, BioUltra, for molecular biology, ≥99.0% (T)
HNa2O4P · 2H2O
30435
Sodium phosphate dibasic dihydrate, puriss. p.a., Reag. Ph. Eur., 98.5-101.0% (calc. to the dried substance)
HNa2O4P · 2H2O
04272
Sodium phosphate dibasic dihydrate, meets analytical specification of Ph. Eur., BP, 98.5-101% (calc. to the dried substance)
HNa2O4P · 2H2O
71645
Sodium phosphate dibasic dihydrate, purum p.a., ≥98.0% (T)
HNa2O4P · 2H2O
71662
Sodium phosphate dibasic dihydrate, tested according to Ph.Eur.
HNa2O4P · 2H2O
RES0974S-A7
Sodium phosphate dibasic dihydrate, PharmaGrade, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
HNa2O4P · 2H2O